68Ga-PSMA-11 dynamic PET/CT in biochemical relapse of prostate cancer

被引：0
|
作者：
Sachpekidis, C. [1 ]
Eder, M. [2 ]
Kopka, K. [2 ]
Mier, W. [3 ]
Hadaschik, B. A. [4 ]
Dimitrakopoulou-Strauss, A. [1 ]
机构：
[1] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Greece
[2] German Canc Res Ctr, Div Radiopharmaceut Chem, Heidelberg, Greece
[3] Heidelberg Univ, Div Nucl Med, Heidelberg, Greece
[4] Heidelberg Univ, Urol Clin, Heidelberg, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P688
引用
收藏
页码：S670 / S670
页数：1
相关论文
共 50 条
  • [31] 68Ga-PSMA-11 Imaging for Biochemical Relapse of Prostate Cancer Using Dual-Time LYSO and SiPM-Based Detectors PET/CT
    Duan, H.
    Park, S.
    Baratto, L.
    Hatami, N.
    Khalaf, M. H.
    Yohannan, T. K.
    Davidzon, G. A.
    Iagaru, A. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S713 - S713
  • [32] Impact of 68Ga-PSMA-11 PET/CT on salvage radiation treatment concept in males with early biochemical relapse of prostate cancer after radical prostatectomy
    Dyankova, M.
    Stoeva, T.
    Dancheva, Z.
    Chausheva, S.
    Yordanova, T.
    Chaushev, B.
    Klisarova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S181 - S182
  • [33] Comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in recurrent Prostate Cancer
    Ceci, F.
    Polverari, G.
    Gartmann, J.
    Fendler, W.
    Eiber, M.
    Herrmann, K.
    Czernin, J.
    Calais, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S150 - S150
  • [34] Dual-time-point dynamic 68Ga-PSMA-11 PET/CT for parametric imaging generation in prostate cancer
    Burasothikul, Paphawarin
    Navikhacheevin, Chatchai
    Pasawang, Panya
    Sontrapornpol, Tanawat
    Sukprakun, Chanan
    Khamwan, Kitiwat
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (09) : 700 - 710
  • [35] Single-Center Prospective Evaluation of 68Ga-PSMA-11 PET in Biochemical Recurrence of Prostate Cancer
    Lawhn-Heath, Courtney
    Flavell, Robert R.
    Behr, Spencer C.
    Yohannan, Thomas
    Greene, Kirsten L.
    Feng, Felix
    Carroll, Peter R.
    Hope, Thomas A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 213 (02) : 266 - 274
  • [36] The role of histopathological and biochemical parameters for predicting metastatic disease on 68Ga-PSMA-11 PET in prostate cancer
    Aydos, Uguray
    cetin, Serhat
    Akdemir, Umit Ozgur
    Budak, Firat Caglar
    Ates, Seda Gulbahar
    Koparal, Murat Yavuz
    Gonul, Ipek Isik
    Gulbahar, Ozlem
    Sozen, Sinan
    Atay, Lutfiye Ozlem
    PROSTATE, 2021, 81 (16): : 1337 - 1348
  • [37] 68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
    Iravani, Amir
    Hofman, Michael S.
    Mulcahy, Tony
    Williams, Scott
    Murphy, Declan
    Parameswaran, Bimal K.
    Hicks, Rodney J.
    CANCER IMAGING, 2017, 17
  • [38] 68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer
    Amir Iravani
    Michael S. Hofman
    Tony Mulcahy
    Scott Williams
    Declan Murphy
    Bimal K. Parameswaran
    Rodney J. Hicks
    Cancer Imaging, 17
  • [39] Pharmacokinetic PET/CT studies with 68Ga-PSMA-11 in patients with biochemical recurrence and progression of a prostatic cancer
    Strauss, D.
    Sachpekidis, C.
    Kopka, K.
    Dimitrakopoulou-Strauss, A.
    Pan, L.
    Haberkorn, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S591 - S591
  • [40] Integration of CT urography improves diagnostic confidence of 68Ga-PSMA-11 PET/CT in prostate cancer patients
    Leon Will
    Frederik L. Giesel
    Martin T. Freitag
    Anne K. Berger
    Walter Mier
    Klaus Kopka
    Stefan A. Koerber
    Hendrik Rathke
    Christophe Kremer
    Clemens Kratochwil
    Hans-Ulrich Kauczor
    Uwe Haberkorn
    Tim F. Weber
    Cancer Imaging, 17
12345